Annual Debt To Equity
-1.28
+0.08+5.88%
December 31, 2023
Summary
- As of February 7, 2025, BBIO annual debt to equity ratio is -1.28, with the most recent change of +0.08 (+5.88%) on December 31, 2023.
- During the last 3 years, BBIO annual debt to equity has fallen by -9.52 (-115.53%).
- BBIO annual debt to equity is now -115.53% below its all-time high of 8.24, reached on December 31, 2020.
Performance
BBIO Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-1.40
+0.17+10.83%
September 30, 2024
Summary
- As of February 7, 2025, BBIO quarterly debt to equity ratio is -1.40, with the most recent change of +0.17 (+10.83%) on September 30, 2024.
- Over the past year, BBIO quarterly debt to equity has dropped by -0.12 (-9.38%).
- BBIO quarterly debt to equity is now -116.99% below its all-time high of 8.24, reached on December 31, 2020.
Performance
BBIO Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
BBIO Debt To Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.9% | -9.4% |
3 y3 years | -115.5% | -9.4% |
5 y5 years | -852.9% | -9.4% |
BBIO Debt To Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +34.7% | -11.1% | +28.6% |
5 y | 5-year | -115.5% | +34.7% | -117.0% | +59.4% |
alltime | all time | -115.5% | +34.7% | -117.0% | +59.4% |
BridgeBio Pharma Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -1.40(-10.8%) |
Jun 2024 | - | -1.57(-4.3%) |
Mar 2024 | - | -1.64(+28.1%) |
Dec 2023 | -1.28(-5.9%) | -1.28(-10.5%) |
Sep 2023 | - | -1.43(+13.5%) |
Jun 2023 | - | -1.26(-10.0%) |
Mar 2023 | - | -1.40(+2.9%) |
Dec 2022 | -1.36(-30.6%) | -1.36(-8.7%) |
Sep 2022 | - | -1.49(-9.7%) |
Jun 2022 | - | -1.65(+0.6%) |
Mar 2022 | - | -1.64(-16.3%) |
Dec 2021 | -1.96 | -1.96(+5.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | -1.85(-37.5%) |
Jun 2021 | - | -2.96(-14.2%) |
Mar 2021 | - | -3.45(-141.9%) |
Dec 2020 | 8.24(+3645.5%) | 8.24(+186.1%) |
Sep 2020 | - | 2.88(+63.6%) |
Jun 2020 | - | 1.76(+45.5%) |
Mar 2020 | - | 1.21(+450.0%) |
Dec 2019 | 0.22(+29.4%) | 0.22(+37.5%) |
Sep 2019 | - | 0.16(-166.7%) |
Jun 2019 | - | -0.24(-209.1%) |
Mar 2019 | - | 0.22(+29.4%) |
Dec 2018 | 0.17(>+9900.0%) | 0.17 |
Dec 2017 | 0.00 | - |
FAQ
- What is BridgeBio Pharma annual debt to equity ratio?
- What is the all time high annual debt to equity for BridgeBio Pharma?
- What is BridgeBio Pharma annual debt to equity year-on-year change?
- What is BridgeBio Pharma quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly debt to equity year-on-year change?
What is BridgeBio Pharma annual debt to equity ratio?
The current annual debt to equity of BBIO is -1.28
What is the all time high annual debt to equity for BridgeBio Pharma?
BridgeBio Pharma all-time high annual debt to equity ratio is 8.24
What is BridgeBio Pharma annual debt to equity year-on-year change?
Over the past year, BBIO annual debt to equity ratio has changed by +0.08 (+5.88%)
What is BridgeBio Pharma quarterly debt to equity ratio?
The current quarterly debt to equity of BBIO is -1.40
What is the all time high quarterly debt to equity for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly debt to equity ratio is 8.24
What is BridgeBio Pharma quarterly debt to equity year-on-year change?
Over the past year, BBIO quarterly debt to equity ratio has changed by -0.12 (-9.38%)